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Loss of the RNA helicase SKIV2L2 impairs mitotic progression
and replication-dependent histone mRNA turnover in murine
cell lines
ALEXIS M. ONDERAK and JAMES T. ANDERSON
Department of Biological Sciences, Marquette University, Milwaukee, Wisconsin 53201, USA

ABSTRACT
RNA surveillance via the nuclear exosome requires cofactors such as the helicase SKIV2L2 to process and degrade certain
noncoding RNAs. This research aimed to characterize the phenotype associated with RNAi knockdown of Skiv2l2 in two
murine cancer cell lines: Neuro2A and P19. SKIV2L2 depletion in Neuro2A and P19 cells induced changes in gene expression
indicative of cell differentiation and reduced cellular proliferation by 30%. Propidium iodide-based cell-cycle analysis of
Skiv2l2 knockdown cells revealed defective progression through the G2/M phase and an accumulation of mitotic cells,
suggesting SKIV2L2 contributes to mitotic progression. Since SKIV2L2 targets RNAs to the nuclear exosome for processing and
degradation, we identified RNA targets elevated in cells depleted of SKIV2L2 that could account for the observed twofold
increase in mitotic cells. Skiv2l2 knockdown cells accumulated replication-dependent histone mRNAs, among other RNAs, that
could impede mitotic progression and indirectly trigger differentiation.
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INTRODUCTION
During the course of transcription, nuclear RNA surveillance
orchestrates the proper processing and turnover of certain
RNAs. The nuclear exosome mediates much of this RNA surveillance to prevent aberrant RNAs from either accumulating
in the nucleus or being exported to the cytoplasm. Highly
conserved, the eukaryotic nuclear exosome consists of a
nine-subunit catalytically inactive core, a trimeric cap that
binds RNA, and accessory proteins consisting of both endonucleases and exonucleases, such as Dis3 and Rrp6 (LykkeAndersen et al. 2009).
The nuclear exosome requires a series of cofactors for
preparation and delivery of RNA substrates (Houseley et al.
2006), and one such cofactor, the Trf4/Air2/Mtr4 polyadenylation (TRAMP) complex, was first discovered in Saccharomyces cerevisiae (LaCava et al. 2005; Houseley et al. 2006). The
TRAMP complex, consisting of the helicase Mtr4p, the
RNA binding protein Air1/2p, and the noncanonical poly(A)
polymerase Trf4/5p, tags nuclear RNAs to be degraded with
a short adenosine tail, guides those RNAs to the exosome,
and then activates the exosome’s exonucleolytic activity
(LaCava et al. 2005; Houseley et al. 2006; Lykke-Andersen
et al. 2009). Trf4/5p adds 3–5 adenosines to RNA substrates
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bound by Air1/2p (Schmidt and Butler 2013). The resulting
A tail not only distinguishes exosome substrates from RNAs
stabilized by a longer poly(A) tail (Andersen et al. 2008), but
also generates the 3′ overhang necessary for the helicase
Mtr4p to bind the RNA and unwind any secondary structure
that would impede entry into the nuclear exosome (LaCava et
al. 2005; Houseley et al. 2006; Andersen et al. 2008; LykkeAndersen et al. 2009; Jia et al. 2012). The yeast TRAMP complex has been found to be essential in RNA surveillance of
certain transcripts, including the turnover of hypomodified
(Wang et al. 2007a,b), 3′ -end trimming of the
tRNAMET
i
5.8S rRNA (de la Cruz et al. 1998), processing of the 7S
rRNA precursor (Callahan and Butler 2009), degradation
of cryptic unstable transcripts (CUTs) arising from heterochromatic regions (Thiebaut et al. 2006), and efficient splicing and intron degradation (Nag and Steitz 2012; Kong et al.
2013).
Recently, the homologs of the yeast TRAMP complex were
found to be highly conserved in mammals, with the poly(A)
polymerase PAPD5 having 37% amino acid sequence identity
to Trf4p in its catalytic domain, ZCCHC7 showing similarity
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to Air1p, and SKIV2L2 retaining 51% amino acid identity
with the helicase Mtr4p (Norbury 2011; Schmidt and Butler
2013). Mtr4p, the yeast homolog of SKIV2L2, has been shown
to function as a DExH-box helicase with 3′ → 5′ helicase activity and ATPase activity (Weir et al. 2010; Norbury 2011).
In addition to the TRAMP complex, mammalian SKIV2L2
interacts with the zinc knuckle protein ZCCHC8 and the
putative RNA-binding protein RBM7 to form the nuclear
exosome targeting (NEXT) complex (Lubas et al. 2011;
Norbury 2011). Studies in mammals suggest that the
TRAMP complex’s location and RNA targets are primarily
nucleolar, while the NEXT complex is located in the nucleoplasm and target nuclear RNAs (Lubas et al. 2011). Research
focused on identifying substrates of the mammalian nuclear
exosome has demonstrated that SKIV2L2 is necessary for
the maturation of ribosomal RNA precursors (Schilders et
al. 2007; Lubas et al. 2011) and facilitates the degradation of
PROMPTs (promoter upstream transcripts) in concert with
the NEXT complex (Tiedje et al. 2014). Furthermore,
PAPD5 has been shown to bind RNA independent of the
TRAMP complex (Rammelt et al. 2011) and modify
miRNAs in vivo to alter their stability (Boele et al. 2014).
Because the helicase SKIV2L2 plays a central role in both
the TRAMP and the NEXT complex, it acts as a key player
in the study of mammalian nuclear RNA surveillance. In
animals, SKIV2L2 has been implicated in development.
Forward genetic screens in zebrafish identified SKIV2L2 as
a possible factor in stem cell maintenance, as mutant zebrafish have reduced brain size and lack the ability to regenerate
melanocytes or regrow tails (Yang et al. 2007; Hultman and
Johnson 2010; Cox et al. 2011). In teleost fishes, Skiv2l2
expression colocalizes with the cell proliferation marker
PCNA (Yang et al. 2007), indicating that Skiv2l2 expression
is enhanced in actively dividing populations of stem cells.
Taken together, the phenotypes associated with loss of
SKIV2L2 in fish indicate that SKIV2L2 may help maintain
stem cell populations. In mammals, preliminary screens suggest siRNA knockdown of Skiv2l2 results in impaired cell
division and death of embryonic stem cells (Fazzio et al.
2008; Neumann et al. 2010). Additionally, Skiv2l2 is downregulated during differentiation, with Skiv2l2 falling within
the top 2% of genes whose expression is positively correlated
with pluripotent embryonic stem cells and negatively correlated with differentiated cells (Cinghu et al. 2014). This trend
has been confirmed in the testes where SKIV2L2 levels
decline in response to testosterone during spermatogenesis
(Osman et al. 2011). Because Skiv2l2 expression and function
appear to be important in development, we focused our studies on how SKIV2L2, and therefore RNA surveillance, might
affect pluripotency and proliferation in mammalian cancer
cell lines.
By using Neuro2A (N2A, ATCC #CCL-131) cells derived
from a murine neuroblastoma (Nilbratt et al. 2009;
Tremblay et al. 2010; Zhi et al. 2012) and P19 cells (ATCC
#CRL-1825) derived from a murine embryonic teratocarci-

noma (Osman et al. 2011), we investigated the role of
Skiv2l2 (Gene ID: 72198) in differentiation and proliferation.
These mammalian cancer cell lines provide a system to investigate cell proliferation and model differentiation, as chemicals induce the differentiation of N2A cells into neurons
(Nilbratt et al. 2009; Tremblay et al. 2010) and P19 cells
into either neurons or myocytes (Jasmin et al. 2010; Dong
et al. 2012). This research sought to characterize the phenotype associated with SKIV2L2 depletion via RNAi and to
identify RNA substrates of SKIV2L2, particularly those that
could affect proliferation or differentiation. Skiv2l2 knockdown cells exhibited changes in cell morphology and gene expression associated with cellular differentiation, including an
increase in cell-fate-specific gene expression and a decrease in
the expression of pluripotency genes. Skiv2l2 knockdown via
RNAi also reduced cellular proliferation, particularly attributed to a slowed progression through the G2/M phase.
While previous research has uncovered a plethora of noncoding RNAs targeted for processing and degradation by the
TRAMP and NEXT complexes, we sought to expand our studies beyond noncoding RNAs. With current known targets
consisting of miRNA 5′ leader sequences (Dorweiler et al.
2014), snoRNAs (Lubas et al. 2015), rRNAs (Berndt et al.
2012), PROMPTs (Tiedje et al. 2014), and lncRNAs
(Beaulieu et al. 2012), our research investigated the possibility
of protein-coding mRNA turnover via the TRAMP and NEXT
complex. In accomplishment of this, RNA-seq identified
SKIV2L2-target RNAs that could be responsible for perturbing mitotic progression. Most notably, replication-dependent
histone mRNAs accumulated following SKIV2L2 depletion.
By demonstrating that SKIV2L2 directly binds histone
mRNAs in vivo and that SKIV2L2 depletion doubles histone
mRNA half-life, these results establish SKIV2L2-mediated
RNA surveillance as essential for replication-dependent histone mRNA turnover.
RESULTS
RNAi-mediated knockdown of Skiv2l2 increases
cell differentiation
To discern the phenotype associated with SKIV2L2 depletion
in Mus musculus cell lines, RNAi was utilized to reduce
Skiv2l2 expression in both N2A and P19 cells. Three
siRNAs were initially tested (siRNA ID #177474, 177475,
177476) for Skiv2l2 knockdown efficiency, and siRNA ID
#177475 was selected for subsequent studies based on knockdown efficiency at low concentrations and consistency (data
not shown, Dorweiler et al. 2014). To address the possibility
of off-target effects, experiments were replicated with siRNA
ID #177476 (Supplemental Fig. S1). Following transfection
with siRNA ID #177475 (Skiv2l2 siRNA), Western blotting
and qRT-PCR confirmed knockdown of Skiv2l2 levels.
When transfected with Skiv2l2 siRNA, N2A cells expressed
on average 6.3-fold less SKIV2L2 protein than N2A cells
www.rnajournal.org
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transfected with nontargeting control siRNA (n = 3, P-value
<0.0004, Fig. 1A), and Skiv2l2 mRNA levels decreased by 7.9fold (n = 3, P-value <0.008) as measured via quantitative RTPCR (qRT-PCR) (Fig. 1B). Initial observations revealed that
following treatment with siRNAs directed against Skiv2l2,
N2A cells failed to grow to 100% confluency, unlike N2A
cells treated with the nontargeting control siRNA (data not
shown). Further inspection revealed increased extension of
axons and dendrites following SKIV2L2 depletion (Fig.

1C), hinting that SKIV2L2 may play a role in maintaining
cancer cell proliferation or preventing differentiation. These
observations led to experiments to determine whether the
phenotype observed with Skiv2l2 knockdown might be due
to increased N2A cell differentiation or reduced proliferation.
To examine the correlation between SKIV2L2 levels and
differentiation, N2A cells were chemically induced to differentiate. Serum starvation and treatment with 20 µM all-trans
retinoic acid (ATRA) initiate the differentiation of N2A cells
into cholinergic neurons (Nilbratt et al.
2009), visualized as the extension of neuronal processes. This differentiation can
also be quantified through the expression
of genes indicative of cholinergic neurons, such as acetylcholine transferase
(ChAT), which is necessary for the biogenesis of acetylcholine (Sidiropoulou
et al. 2008), and the axonal-specific β-tubulin-III (Tubb3) (Supplemental Fig.
S2A; Zhi et al. 2012). Western blotting
revealed that chemically differentiated
N2A cells express ∼50% less SKIV2L2
protein when compared to N2A cells
grown in standard growth media containing 10% fetal bovine serum (P-value
<0.0001, Fig. 1A). As measured via
qRT-PCR, Skiv2l2 mRNA levels were reduced by 4.3-fold in chemically differentiated N2A cells (P-value <0.003, Fig.
1B). Further studies have demonstrated
that this reduction is not due to posttranscriptional control via the 3′ UTR
of Skiv2l2 (Supplemental Fig. S3), suggesting that this down-regulation might
be due to developmental changes in
transcription.
Upon observation that differentiation
in N2A cells down-regulates Skiv2l2, we
hypothesized that SKIV2L2 depletion enhances differentiation. Both the quantification of N2A cells extending neuronal
processes (axons and dendrites) and the
measurement of differentiation marker
expression were utilized to determine
FIGURE 1. Knockdown of Skiv2l2 in N2A cells enhances differentiation into neurons. (A) whether Skiv2l2 knockdown enhances
Western blots to detect SKIV2L2 protein in whole-cell extract from cells transfected with nontargeting control siRNA or Skiv2l2 siRNA. N2A cells transfected with control siRNA were grown in the differentiation of N2A cells into neueither 10% fetal bovine serum or 2% fetal bovine serum with 20 µM ATRA to induce differenti- rons. N2A cells extending processes were
ation. SKIV2L2 protein levels (118 kD) were normalized to β-actin protein levels (42 kD). (B) counted in both control siRNA- and
qRT-PCR of Skiv2l2 mRNA from N2A cells treated with control siRNA, ATRA, or Skiv2l2 Skiv2l2 siRNA-transfected cells (Fig.
siRNA. Skiv2l2 mRNA levels measured via ΔCq values were normalized to β-actin mRNA.
Error bars represent ±SD for n = 3. (C ) Neurite outgrowth imaging. Scale is 250 µM. 1C). Skiv2l2 knockdown resulted in a
Neuronal processes (marked by arrowheads) were observed among N2A cells and counted. 20% increase in cells extending long neu(D) qRT-PCR of neuronal differentiation markers. Tubb3 and ChAT mRNA levels were calculated ronal processes over control cells
from ΔCq values and normalized to β-actin mRNA levels in control and Skiv2l2 siRNA-treated
(Supplemental Fig. S4, P-value <0.05).
N2A cells (error bars represent ±SD, n = 3). (E) qRT-PCR of pluripotency markers Nestin and
As N2A cells differentiate, genes specifSox2. Nestin and Sox2 mRNA levels were calculated as stated above (error bars represent ±SD
ic to neurons, such as ChAT and Tubb3,
for n = 3).
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are transcribed, while pluripotency genes
such as Sox2 and Nestin are silenced (Zhi
et al. 2012; Supplemental Fig. S2A).
Measured via qRT-PCR, Tubb3 expression increased 2.0-fold (P-value <0.048)
and ChAT expression increased 3.2-fold
following SKIV2L2 depletion (P-value
<0.0001) (Fig. 1D). This increase in
Tubb3 and ChAT expression, representative of axon structure and function, is
consistent with the enhanced neuronal
cell morphology in Skiv2l2 knockdown
cells. Furthermore, the expression of pluripotency markers Nestin and Sox2 was
found to exhibit a 2.97-fold decrease (Pvalue <0.03) and a 2.98-fold decrease
(P-value <0.01), respectively, in Skiv2l2
knockdown cells when compared to control siRNA-treated cells (Fig. 1E). The increase in neuronal cell morphology,
elevated Tubb3 and ChAT expression,
and loss of pluripotency markers suggest
that decreased levels of SKIV2L2 result
in loss of multipotency and enhanced differentiation in N2A cells. Depletion of
TRAMP component Papd5 via siRNA
(siRNA ID #s103146) also increased
extension of neuronal processes and
higher Tubb3 and ChAT mRNA levels
(Supplemental Fig. S5), suggesting that
the observed phenotype relates to loss of FIGURE 2. Knockdown of Skiv2l2 in P19 cells enhances differentiation into cardiomyocytes. (A)
RNA surveillance as opposed to off-target Western blot to detect SKIV2L2 protein in P19 whole-cell extract from cells transfected with control siRNA, Skiv2l2 siRNA, or grown in 0.1% DMSO. SKIV2L2 protein levels (118 kD) were noreffects.
malized to β-actin (42 kD). (B) qRT-PCR of Skiv2l2 mRNA in P19 cells. Skiv2l2 mRNA levels in
We next explored the possibility that control siRNA-treated cells, 0.1% DMSO-treated cells, and Skiv2l2 siRNA-treated cells were meaSkiv2l2 knockdown triggers cell differen- sured via ΔCq values and normalized to β-actin (error bars represent ±SD for n = 4). (C) qRTtiation in multiple cell types by repeating PCR of myocyte differentiation transcription factors in P19 cells. GATA4 and Nkx2.5 mRNA levels calculated as in B (error bars represent ±SD for n = 3). (D) qRT-PCR of myocyte differentiRNAi knockdown of Skiv2l2 in the ation markers in P19 cells. Fabp3 and Desmin mRNA levels calculated as in B (error bars
mouse embryonic teratocarcinoma line, represent ±SD for n = 3). (E) qRT-PCR of pluripotency markers Sox2 and Nanog in P19 cells.
P19. Skiv2l2 knockdown in P19 cells re- Sox2 and Nanog mRNA levels calculated as in B (error bars represent ±SD for n = 3).
sulted in a 70% reduction in SKIV2L2
protein levels compared to control
Gene transcripts selected to screen for differentiation includsiRNA-treated cells (P-value <0.0001, Fig. 2A) and an eighted the cardiac muscle transcription factors GATA4 and
fold decrease in Skiv2l2 mRNA levels (P-value <0.01, n = 4).
Nkx2.5 (Choi et al. 2004), fatty-acid binding protein 3
Differentiation of P19 cells into cardiac myocytes with
(Fabp3) specific to cardiac muscle (Zhu et al. 2011), and
DMSO resulted in a significant 86% decrease in SKIV2L2
the intermediate filament Desmin expressed in all muscle
protein levels (P-value <0.04, Fig. 2A) and a threefold
cell types (Supplemental Fig. S2B; Choi et al. 2004; Dey
decrease in Skiv2l2 mRNA levels (P-value <0.03, Fig. 2B).
et al. 2010). High levels of the transcription factors Nanog
This demonstrates that differentiation into multiple cell
(Zhu et al. 2011) and Sox2 (Dong et al. 2012) characterize
types, specifically cholinergic neurons and cardiac myocytes,
P19 cell pluripotency (Supplemental Fig. S2B). Following
correlates with a down-regulation of SKIV2L2. Due to the
Skiv2l2 knockdown, both GATA4 and Nkx2.5 mRNA levels
ability of P19 cells to form cardiac muscle, skeletal muscle,
increased 3.9-fold above those found in P19 cells treated
and various neurons, the phenotype of P19 cells following
with control siRNA (Fig. 2C, P-values <0.0008, 0.008).
Skiv2l2 knockdown was examined through qRT-PCR of carFabp3 expression was elevated 1.8-fold (P-value <0.02),
diac myocyte markers and pluripotency markers, as cell morand Desmin expression increased 2.6-fold (Fig. 2D, P-value
phology was not a reliable measurement of differentiation.
www.rnajournal.org
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<0.04) in Skiv2l2 knockdown cells. Overall, the expression
pattern following SKIV2L2 depletion in P19 cells indicates
enhanced differentiation into cardiac myocytes. Down-regulation of the pluripotency transcription factors Sox2 and
Nanog by 50-fold (P-value <0.0001) and 2.3-fold (P-value
<0.04), respectively, denote a shift in P19 cells from a pluripotent to a more differentiated state following Skiv2l2 knockdown (Fig. 2E; Dey et al. 2010; Zhu et al. 2011; Dong et al.
2012). Therefore, RNAi against Skiv2l2 promotes differentiation into both neurons in N2A cells and cardiac myocytes in
P19 cells.
SKIV2L2 depletion impairs cellular proliferation
Since SKIV2L2 depletion enhanced differentiation into two
cell types in two different murine cell lines, we hypothesized
that SKIV2L2 might affect cellular proliferation, consequently influencing the differentiation phenotype observed.
Differentiation and proliferation are often viewed as antagonistic processes because cell-cycle arrest in the G1 phase usually precedes cell differentiation (Liu et al. 2013). The
majority of terminally differentiated cells lose the ability to
divide, with new cells coming only from a stem cell pool.
Additionally, many cancer cell lines, including N2A cells, differentiate following serum starvation, indicating that the
growth factors that keep cancer cell lines proliferating are
necessary to prevent their differentiation (Phillips et al.
2006). Since slowed cellular proliferation due to cell-cycle arrest could result in the increased differentiation seen with
Skiv2l2 knockdown, experiments were utilized to determine
whether reduced SKIV2L2 levels impair progression through
the cell cycle.
MTT assays were used to quantify the proliferation of both
N2A and P19 cells transfected with either control or Skiv2l2
siRNA. MTT assays estimate the relative number of proliferating cells, because only proliferating cells are capable of
reducing MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to purple formazan crystal (Freimoser
et al. 1999; Xie et al. 2010; Gui et al. 2014). Lower levels of
MTT reduction correspond to a decrease in the number of
proliferating cells, which could be due to cell death, cell differentiation, or slower progression through the cell cycle
(Freimoser et al. 1999). In both N2A cells and P19 cells,
SKIV2L2 depletion resulted in decreased formazan production. Skiv2l2 knockdown in N2A cells resulted in a 38% (Pvalue <0.0001) overall decrease in formazan production
(Supplemental Fig. S6). Time course MTT assays revealed
that the proliferation of both ATRA-treated cells and
Skiv2l2 knockdown cells slowed similarly over time (Fig.
3A), with Skiv2l2 siRNA resulting in a 22% reduction in proliferation at 28 h (P-value <0.0007) and a 27% reduction at
32 h when compared to control siRNA-treated cells (P-value
<0.002). In P19 cells, Skiv2l2 knockdown cells showed a similar 30% decrease in formazan production when compared to
cells transfected with control siRNA (Fig. 3B, P-value <0.04).
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FIGURE 3. Skiv2l2 knockdown results in delayed proliferation attributed to slowed G2/M phase progression. (A) MTT time point assay in
N2A cells. Absorbance of formazan (570 nm) at 24, 28, and 32 h following treatment with control siRNA, ATRA, or Skiv2l2 siRNA (n = 4
for each time point, [∗ ] represents P-value <0.05). (B) MTT assay in
P19 cells. Absorbance of formazan was measured after 48 h of treatment with control siRNA, ATRA, or Skiv2l2 siRNA (error bars represent ±SD for n = 9). (C) Propidium iodide viability staining of N2A
cells. Fluorescing cells (dead or necrotic) detected by the FL-2 filter
are circled, and the Accuri C6 software was used to quantify the percentage of control, ATRA treated, and Skiv2l2 knockdown cells staining with propidium iodide. (D) Cell-cycle analysis with propidium
iodide staining of fixed N2A cells. Cells treated with control siRNA,
Skiv2l2 siRNA, or ATRA were excited at 488 nm and sorted using
FL-2 on the Accuri C6 based on propidium iodide fluorescence. The
sorted cells corresponded to G1, S, and G2/M phase as denoted. (E)
Quantification of cell-cycle profile. Based on the cell-cycle landscapes
generated in D, the Accuri C6 software was used to calculate the percentage of cells in G1, S, and G2/M phase, where n = 3 sets of 50,000
cells and statistically significant differences (P-value <0.05) are denoted with an asterisk (∗ ).
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This result demonstrates a 22%–38% reduction in the number of proliferating cells following SKIV2L2 depletion.
Because the MTT assay measures overall proliferation, it
was possible that reduced proliferation of Skiv2l2 knockdown
cells could be due to cell death. Therefore, a two-pronged approach was utilized to measure cell proliferation: MTT assays
to directly measure the relative amount of proliferative cells
and propidium iodide staining to measure cell death. N2A
cells were stained with propidium iodide, which passes
through the compromised membranes of dead cells and binds
to DNA (Lima et al. 2008). Quantifying the percentage of dead
and necrotic cells staining with propidium iodide through
FACs analysis revealed that transfection of N2A cells with control siRNA and differentiation with ATRA resulted in a 14%
cell death rate (P-value <0.72, n = 3). In contrast, Skiv2l2
knockdown did not result in significant cell death, as only
5% of Skiv2l2 knockdown cells stained with propidium iodide
(P-value <0.0001, n = 3) (Fig. 3C). There was no statistically
significant change in the profile of cells staining with low levels of propidium iodide, possibly representing apoptotic cells
(P-values all >0.05). In addition, granularity was measured via
side-scattering versus forward-scattering. Cells demonstrating increased side-scattering with low forward-scattering are
associated with apoptosis, and the percentage of cells meeting
this criterion were quantified for each sample (Darzynkiewicz
et al. 1992). This calculation showed that while ATRA treatment increased the number of cells with high side-scattering
(P-value <0.0096), there was no difference between the control siRNA and Skiv2l2 siRNA-treated samples (P-value <0.2).
This denotes that increased cell death could not account for
the reduced levels of proliferation seen in the MTT assay following SKIV2L2 depletion.
Since Skiv2l2 knockdown results in increased differentiation, we hypothesized that loss of SKIV2L2 might cause G1
arrest followed by differentiation. The cell cycle was examined through fluorescent-activated cell sorting of fixed N2A
cells stained with propidium iodide. Cells were sorted based
on the intensity of propidium iodide fluorescence, which correlates to DNA content (Fig. 3D,E; Krishan 1975; Zhi et al.
2012; Wesley et al. 2015). For N2A cells transfected with
the control siRNA, 44.5% of cells were found to be in G1
phase, as they possess half the DNA content of cells in G2
phase and therefore half the intensity of propidium iodide
fluorescence. Smaller proportions of cells were observed in
S phase (26.6%) and G2/M phase (28.8%), both denoted
by increased DNA content and propidium iodide fluorescence. As expected, differentiation of N2A cells with ATRA
induced a small but significant 11% increase in the proportion of cells in G1 phase compared to control cells (P-value
<0.0025). Surprisingly, SKIV2L2 depletion did not cause
G1 arrest like chemically induced differentiation. Instead,
37.2% of Skiv2l2 knockdown cells exhibited double the
DNA content, which is indicative of G2/M phase arrest.
This modest but statistically significant 23% increase (P-value
<0.000001) in G2/M phase cells implies that loss of SKIV2L2

hinders the progression of cells through G2/M phase, which
is distinct from G1 phase arrest seen in chemically differentiating N2A cells. Overall, both the reduced proliferation and
G2/M phase arrest observed following SKIV2L2 depletion
suggest SKIV2L2 helps maintain cell proliferation.
Skiv2l2 knockdown impairs mitotic progression
Following observance of delayed G2/M phase progression after Skiv2l2 knockdown, further experiments aimed to determine whether SKIV2L2 depletion impaired the G2 or mitotic
phases of the cell cycle. Phosphorylation of serine 10 on histone H3 is a well-accepted marker of mitosis, as H3 phosphoS10 increases with chromosome condensation during mitosis
(Crosio et al. 2002). To examine whether SKIV2L2 depletion
impedes mitotic progression, Western blots were performed
to detect phosphorylated H3 (H3 phospho-S10) in control
and knockdown N2A cells. Whole-cell extracts were fractionated into cytoplasmic and nuclear fractions. Histone proteins
were acid-extracted from the nuclear fraction for analysis,
while the β-actin protein was detected in the cytoplasmic
fraction. Skiv2l2 knockdown N2A cells exhibited an average
2.5-fold increase in overall H3 phospho-S10 levels compared
to control cells (Fig. 4A, n = 8, P-value <0.0071). The experiment was replicated in P19 cells, where Skiv2l2 knockdown
resulted in a fourfold increase in H3 phospho-S10 over control levels (Fig. 4B, n = 8, P-value <0.04).
However, this increase in H3 phospho-S10 could correlate
with increased overall histone levels in G2/M phase.
Therefore, indirect immunofluorescence microscopy was
used to count the number of cells positive for the H3 phospho-S10 marker (Fig. 4C). This would confirm that the overall increase in H3 phospho-S10 correlates to an increase in
cells in mitosis. Using this method, 10.7% (±4.3% SD) of
cell nuclei staining with propidium iodide also expressed
H3 phospho-S10 in control siRNA-treated N2a cells.
Comparatively, treatment with Skiv2l2 siRNA resulted in
20.1% (±4.3% SD) of cell nuclei staining with the mitotic
marker H3 phospho-S10 antibody (Fig. 4C). This represents
nearly a twofold increase in cells expressing H3 phospho-S10
following Skiv2l2 knockdown (n = 4, P-value <0.02), which
is similar to the average 2.5-fold increase in overall H3 phospho-S10 levels measured via Western blotting. FACs analysis
based on the detection of H3 phospho-S10 replicated this observed doubling in mitotic cells with SKIV2L2 depletion
(Supplemental Fig. S7). Interestingly, binucleated cells were
observed in Skiv2l2 knockdown cells at a 5% incidence rate
(Fig. 4B), denoted by arrows, while no binucleated cells
were observed in control cells (0% incidence rate). These observed binucleated cells depict a delay or failure in cytokinesis
following SKIV2L2 depletion. Together, reduced SKIV2L2
levels increased the number of mitotic cells, suggesting impaired mitotic progression, and resulted in binucleation in
a subset of cells expressing the mitotic marker H3 phospho-S10.
www.rnajournal.org
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We reasoned that the inhibition of RNA surveillance via
Skiv2l2 knockdown might result in the accumulation of
RNAs that could account for the mitotic arrest observed.
Therefore, RNA-seq data obtained from P19 cells treated
with control or Skiv2l2 siRNA were interrogated to identify
changes in the transcriptome that might be indicative of proliferation defects. GO-ontology analysis indicated SKIV2L2
depletion correlates with misregulation of genes involved
with the DNA damage response, signaling-induced cell proliferation, mitotic cyclins, chromatin remodeling, and mitotic spindle assembly. Figure 4E depicts a subset of these
misregulated genes. Of particular interest, cells depleted of
SKIV2L2 showed higher expression of cyclin-G1 (Kimura
et al. 2001), which accumulates in G2/M phase arrested cells,
and lower expression of both the G1–S phase transition cyclin-D1 (Matsuura et al. 2004) and the mitotic progression
cyclin-B2 (Wu et al. 2010). This cyclin expression pattern
is indicative of cells arrested in G2/M phase. Additionally,
GO-ontology analysis of misregulated genes in Skiv2l2
knockdown cells revealed certain genes that positively influence cell proliferation were down-regulated (P-value <0.03),
while specific anti-apoptotic genes were up-regulated (P-value <0.001). Together, this affirms that the observed defects in
cell proliferation correlates with changes in gene expression.
Various classes of RNAs accumulate in Skiv2l2
knockdown cells

FIGURE 4. Skiv2l2 knockdown leads to delayed progression through
mitosis. (A) Western blot to detect histone H3 phosphorylated on serine
10 (H3 phospho-S10) in N2A cells. H3 phospho-S10 protein (17 kD)
levels from nuclear fractions following acid extraction were normalized
to β-actin detected in the cytoplasmic fraction from whole-cell extracts
from control and Skiv2l2 knockdown cells. (B) Western blot to detect
H3 phospho-S10 normalized to β-actin protein levels in P19 cells.
Performed as stated previously on acid-extracted nuclear and cytoplasmic fractions from control or Skiv2l2 siRNA-treated P19 cells. (C )
Indirect immunofluorescent staining of H3 phospho-S10 in N2A cells.
Propidium iodide and H3 phospho-S10 antibody, followed by detection
with anti-rabbit AlexaFluor488, stained mitotic cells, 15 µM scale bar for
top six panels, 20 µM for bottom two panels. (D) Quantification of H3
phospho-S10 staining nuclei. Nuclei densely staining with H3 phospho-S10 antibody were divided by the number of nuclei staining with
propidium iodide to obtain the percentage of nuclei undergoing mitosis
(n = 4, P-value <0.02). (E) Graph of cell-cycle control genes with differential expression in Skiv2l2 knockdown cells detected via RNA-seq in
P19 cells. Up-regulated and down-regulated genes, shown respectively
as above and below zero, in Skiv2l2 knockdown cells found to be involved in cell-cycle control. Statistically significant changes in RNA levels have a q-value of <0.05.
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Those RNAs that accumulate in cells depleted of SKIV2L2
potentially represent two classes of RNAs: direct RNA targets
of SKIV2L2-mediated processing or turnover and RNAs
whose levels change indirectly due to loss of nuclear RNA
surveillance. The RNA-seq study in P19 cells sought to identify RNAs that change abundance following SKIV2L2 depletion, and effort focused on discovering potential direct
targets of SKIV2L2 that might perturb mitosis upon their accumulation. RNA-seq was performed on total RNA isolated
from control siRNA and Skiv2l2 siRNA-treated P19 cells.
RNA was treated with DNase and RiboZero to eliminate
DNA and rRNA prior to sequencing via Illumina Hi-Seq
2000 paired end sequencing. Sequenced reads were mapped
to the mm10 genome build via TopHat, and differential
changes in RNA levels were detected and calculated via cufflinks and cuffdif. In this manner, 1473 RefSeq genes were
identified as dysregulated in Skiv2l2 knockdown cells
(Supplemental Tables S1, S2). Of these, 585 genes were elevated following Skiv2l2 knockdown, while 887 genes were reduced, with <5% potentially being false discoveries (q-value
<0.05). Elevated genes (337) and reduced genes (428) showing greater than a 1.5-fold change were probed in further detail (Supplemental Table S6). Of these, genes elevated in the
Skiv2l2 knockdown samples included 36 replication-dependent histone mRNA genes, 47 noncoding RNAs, and 254
other mRNAs (Fig. 5A). Genes showing decreased steadystate levels in cells depleted of SKIV2L2 included 416
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FIGURE 5. Replication-dependent histone mRNAs accumulate in Skiv2l2 knockdown cells. (A) Transcripts up-regulated in P19 cells following
Skiv2l2 knockdown as measured by RNA-seq. Transcripts up-regulated in Skiv2l2 knockdown cells were categorized based on coding and noncoding
annotations (q-value <0.05, >1.5-fold change). (B) Transcripts down-regulated in P19 cells following Skiv2l2 knockdown as measured by RNA-seq.
Transcripts down-regulated in Skiv2l2 knockdown cells categorized based on coding and noncoding annotations (q-value <0.05, >1.5-fold change).
(C ) qRT-PCR of histone mRNAs in N2A cells. Histone mRNA levels were calculated using ΔCq values and normalized to β-actin mRNA (error bars
represent ±SD for n = 3). (D) qRT-PCR of histone mRNAs in P19 cells. Histone mRNA levels calculated as in C (error bars represent ±SD for n = 3).

mRNAs, 10 noncoding RNAs, and only two noncanonical
histone mRNA transcripts (Fig. 5B). Additionally, 772 intergenic regions of the mouse genome were significantly elevated, while only 99 intergenic regions were down-regulated,
suggesting that SKIV2L2 depletion causes a substantial increase in intergenic transcripts (Supplemental Tables S1,
S3). A fraction of these intergenic regions contain retrogenes
and pseudogenes annotated on the UCSC Genome Browser,
while some of these intergenic regions fall upstream of promoters, possibly representing PROMPTs (promoter upstream transcripts), a known target of nuclear RNA
surveillance (Tiedje et al. 2014; Lubas et al. 2015). Since noncoding RNAs represent the majority of RNAs previously discovered as targets of the TRAMP complex, these noncoding
RNAs were closely inspected. Long noncoding RNAs
(lncRNAs) represented the majority of accumulating noncoding RNAs. Other up-regulated noncoding RNAs included
both new and previously reported RNA surveillance targets:
miRNAs, snoRNAs, and small nuclear RNAs such as MRP
RNA and ribonuclease P RNA (Supplemental Fig. S8;
Schilders et al. 2007; Dorweiler et al. 2014; Tiedje et al.
2014; Lubas et al. 2015).
Interestingly, certain trends emerged in the RNA-seq data.
While previous research focused on noncoding RNA targets
of nuclear RNA surveillance, at least three types of coding
RNAs noticeably accumulate in Skiv2l2 knockdown cells.

First, imprinted genes were overrepresented among genes
dysregulated following SKIV2L2 depletion. Out of the 129
imprinted genes in the mouse genome, 16 were found to
have changed expression in Skiv2l2 knockdown cells, which
is a statistically significant overrepresentation of imprinted
genes among those dysregulated (P-value <2.52 × 10−6,
Supplemental Table S4). In addition to imprinted genes, a
statistically significant change in ribosomal protein mRNAs
emerged in Skiv2l2 knockdown cells. Approximately onethird of all ribosomal protein mRNAs accumulated with
SKIV2L2 depletion, with no ribosomal protein mRNAs being
down-regulated, which is a statistically significant link between SKIV2L2 and ribosomal protein mRNA regulation
(26 out of 39, P-value <4.59 × 10−20). Finally, histone
mRNAs were found to be significantly overrepresented in
the data (P-value <1.85 × 10−57). Forty-eight out of 60 histone genes (80%) were dysregulated in cells depleted of
SKIV2L2. Replication-dependent histone mRNAs consistently accumulated in Skiv2l2 knockdown cells, while two noncanonical histone mRNA transcripts, H2A.x and H2A.z, were
down-regulated (Supplemental Table S5). Analysis of the
RNA-seq reads suggests that these accumulating RNAs are
not 3′ extended or misprocessed mRNAs, with reads from
control and Skiv2l2 siRNA cells mapping to identical positions (Supplemental Fig. S9). These findings confirm the involvement of SKIV2L2-dependent RNA surveillance in the
www.rnajournal.org
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turnover of noncoding RNAs (Schilders et al. 2007; Dorweiler
et al. 2014; Tiedje et al. 2014; Lubas et al. 2015), and, more importantly, they suggest that SKIV2L2-dependent RNA surveillance helps facilitate the degradation of certain coding
RNAs, specifically replication-dependent histone mRNAs.

in the eluate from control anti-goat IgG (Fig. 6A,B). RNAs immunoprecipitated with anti-SKIV2L2 were compared to
those RNAs immunoprecipitated with the control antibody

SKIV2L2 depletion impairs replication-dependent
histone mRNA turnover
The sequencing data from P19 cells insinuated that SKIV2L2
is necessary for efficient turnover of replication-dependent
histone mRNAs. To our knowledge, nuclear turnover of histone mRNAs has not been reported in mammalian cells.
Studies have decisively shown that cytoplasmic histone
mRNA turnover occurs following histone mRNA uridylation,
but these reports conflict on the involvement of PAPD5 in this
process (Kaygun and Marzluff 2005a,b; Marzluff et al. 2008;
Mullen and Marzulff 2008; Schmidt et al. 2010). However,
the fact that Trf4p, the yeast homolog of PAPD5, and the
TRAMP complex have been implicated in histone mRNA
turnover in yeast (Reis and Campbell 2006; Canavan and
Bond 2007) prompted further investigation into the possibility that SKIV2L2 mediates the degradation of histone mRNAs
in Mus musculus. Moreover, accumulation of histone mRNAs
and proteins have been shown to induce mitotic arrest in eukaryotes (Singh et al. 2010), making histone mRNAs a potential candidate responsible for the observed delayed mitotic
progression in Skiv2l2 knockdown cells.
Quantitative RT-PCR verified that the replication-dependent histone transcripts hist1h1b (H1), hist1h2an (H2A),
hist1h2bc (H2B), hist1h3a (H3), and hist1h4d (H4) were significantly elevated in both N2a cells and P19 cells following
Skiv2l2 knockdown (Fig. 5C,D, P-values <0.05). Attempts
to detect histones following reverse transcription with oligo
(dT) were unsuccessful, suggesting that the accumulating
histones lack long poly(A) tails. However, this does not eliminate the possibility that these histone mRNAs are uridylated
or possess short A tails.
In order to support the assertion that replication-dependent histone mRNA turnover requires SKIV2L2, experiments
sought to demonstrate that SKIV2L2 binds histone mRNAs in
vivo, thereby establishing a direct, physical link between
SKIV2L2 and histone mRNA. In addition, evidence that loss
of SKIV2L2 leads to a reduction in histone mRNA turnover
and an increase in histone mRNA half-life would further support the notion of SKIV2L2-mediated turnover of replicationdependent histone mRNAs. To demonstrate that histone
mRNAs directly associate with SKIV2L2, cross-linked immunoprecipitation was performed to detect histone mRNAs
bound to SKIV2L2. Both N2A and P19 cells were irradiated
with UV light to crosslink RNA to protein, and proteins
were bound to beads coated with antibodies directed against
either SKIV2L2 or a negative control goat IgG. Western blots
demonstrated that anti-SKIV2L2 successfully pulled down
∼10% of cellular SKIV2L2, while no SKIV2L2 was detected
918
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FIGURE 6. SKIV2L2 binds to and modulates the half-life of replication
dependent histone mRNAs. (A) Western blot to detect immunoprecipitated SKIV2L2 in N2A cells. Western blots to detect SKIV2L2 were performed on the following samples from N2A cells. (Lane 1) Whole-cell
extract incubated with anti-goat IgG. (Lane 2) Immunoprecipitate
with anti-goat IgG. (Lane 3) Whole-cell extract incubated with antiSKIV2L2. (Lane 4) Immunoprecipitate with SKIV2L2. The top band indicates the position of SKIV2L2, and the lower band represents the heavy
chain from the antibody used for immunoprecipitation. (B) Western
blot to detect immunoprecipitated SKIV2L2 in P19 cells. Western blots
to detect SKIV2L2 were performed in P19 cells as stated above. (Lane 1)
Whole-cell extract incubated with anti-goat IgG. (Lane 2) Immunoprecipitate with anti-goat IgG. (Lane 3) Whole-cell extract incubated with
anti-SKIV2L2. (Lane 4) Immunoprecipitate with SKIV2L2. (C) qRTPCR of histone RNAs bound to immunoprecipitated SKIV2L2 in N2A
cells. Proteins were extracted from N2A cells irradiated with UV light.
SKIV2L2 was immunoprecipitated with its cross-linked RNAs using
anti-SKIV2L2, with anti-goat used as a negative control. RNA was isolated from both anti-SKIV2L2 and anti-goat immunoprecipitates. Using
qRT-PCR, RNA abundance levels of histone mRNAs immunoprecipitated in either sample were calculated using ΔCq values, and normalized to
the amplification of Skiv2l2 mRNA, which was unbound in both samples
(error bars represent ±SD for n = 3). Immunoprecipitated retro-Phgdh
represents an RNA precipitated equally by anti-goat and anti-SKIV2L2.
(D) qRT-PCR of histone RNAs bound to immunoprecipitation SKIV2L2
in P19 cells. Performed as stated in C on immunoprecipitate from P19
cells. (E) Northern blot demonstrating H4 mRNA turnover following
Dactinomycin treatment. Following transfection with control or Skiv2l2
siRNA, RNA was extracted at 0, 1, 2, 3, and 4 h following application of
Dactinomycin. Northern blotting detected H4 mRNA, which was quantified and normalized to ribosomal RNA levels to calculate half-life.
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using quantitative RT-PCR. Histone mRNA levels in immunoprecipitates were normalized against Skiv2l2 mRNA, which
showed no binding to SKIV2L2. Compared to RNA immunoprecipitated with anti-goat IgG, replication-dependent histone mRNAs (H1, H2A, H2B, H3, and H4) were elevated
among RNAs immunoprecipitated with anti-SKIV2L2, as
measured via qRT-PCR (Fig. 6C,D, all P-values <0.05). In
N2A cells, H1, H2A, and H4 were enriched among those
RNAs pulled down with anti-SKIV2L2 by more than fivefold,
while H2B and H3 was found at levels fourfold and twofold
above the control, respectively (Fig. 6C). Among those
RNAs that immunoprecipitated with SKIV2L2, retro-Phgdh
mRNA levels were not above those seen in the control immunoprecipitate, suggesting that the protocol sufficiently distinguished between RNAs bound to SKIV2L2 and unbound
RNA. P19 cells proved to yield a more dramatic result, with
H1, H2A, and H3 being pulled down with anti-SKIV2L2 at
levels 20-fold or greater above those seen in control cells
(Fig. 6D).
In an attempt to further support the hypothesis that
SKIV2L2 is involved with replication-dependent histone
mRNA turnover, the half-life of H4 mRNA was measured
in both control and Skiv2l2 knockdown cells. N2A cells
were treated with Dactinomycin to inhibit RNA polymerase
II transcription, and Northern blots allowed for the visualization of H4 mRNA levels over time. Histone H4 mRNA was
selected as all nine H4 mRNAs expressed from histone cluster
one significantly accumulated with SKIV2L2 depletion as
identified via RNA-seq, and there are no noncanonical H4
variants that could be detected. In N2a cells, qRT-PCR identified a threefold increase in histone H4 mRNA with Skiv2l2
knockdown. Northern blots detected a twofold increase in
histone H4 mRNA (P-value <0.04, n = 3), which is similar
to the accumulation seen via qRT-PCR, demonstrating that
Northern blotting is sensitive enough to discriminate differences in H4 mRNA levels (Fig. 6E). Cells were then treated
with Dactinomycin to observe histone H4 mRNA turnover
in the absence of transcription. Histone H4 mRNA levels
were monitored at five time points following Dactinomycin
treatment, ranging from 0 to 4 h. H4 mRNA levels were detected via Northern blotting, quantified using ImageJ software, and normalized to ribosomal RNA levels to account
for differences in load. In control cells, H4 mRNA was depleted to negligible levels 4 h after Dactinomycin treatment (Fig.
6E). However, at 4 h post-Dactinomycin treatment, Skiv2l2
knockdown cells retained higher levels of H4 mRNA (Fig.
6E; Supplemental Fig. S10), demonstrating that cells depleted
of SKIV2L2 exhibit a decreased rate of H4 mRNA turnover.
The mRNA half-life for histone H4 was calculated at each
time point over 4 h for three separate trials. Based on the average of three independent trials, the half-life of H4 mRNA in
control cells was 34 min, and this half-life increased to 72 min
following Skiv2l2 knockdown (P-value <0.04). Given that
Dactinomycin inhibited transcription in these samples, a
slower rate of mRNA decay must be responsible for the in-

crease in H4 mRNA half-life. Since replication-dependent
histone mRNAs immunoprecipitated with SKIV2L2 at high
levels, these results conclusively demonstrate SKIV2L2
directly binds to histone mRNAs in vivo. Coupled with the
doubling of H4 mRNA half-life following SKIV2L2 depletion, we conclude that SKIV2L2 directly aids in the turnover
of replication-dependent histone mRNAs.
DISCUSSION
Here, we have demonstrated that RNAi knockdown of Skiv2l2
increased differentiation of two murine cell lines into two cell
fates. This differentiation correlates to a decrease in cellular
proliferation, attributed to delayed mitotic progression following Skiv2l2 knockdown. The observed binucleated cells
could arise via “mitotic slippage” where activation of the spindle assembly checkpoint temporarily arrests cells in mitosis,
but the checkpoint cannot be maintained, causing cells to aberrantly continue through mitosis and undergo failed cytokinesis (Rieder and Maiato 2004; Stevens et al. 2007; Freije et al.
2014; Dikovskaya et al. 2015). Examining potential RNAs targeted by SKIV2L2 revealed that SKIV2L2 directly binds to
replication-dependent histone mRNAs, which are elevated
in cells depleted of SKIV2L2 due to a slower decay rate.
Taken together, these results are highly suggestive of the involvement of RNA surveillance factor SKIV2L2 in histone
mRNA turnover, where SKIV2L2 binds histone mRNAs to
mediate their degradation.
Because differentiation reduces Skiv2l2 protein and mRNA
levels, we conclude that Skiv2l2 regulation occurs at the transcriptional level. Additionally, the presence of a CpG island
promoter that Skiv2l2 shares with another RNA helicase,
Dhx29, implies that DNA methyltransferases may developmentally regulate Skiv2l2 transcription. ChIP data suggest
that multiple transcription factors such as STAT3 (Chen
et al. 2008; Hutchins et al. 2012), CREB (Lesiak et al.
2013), E2F1 (Chen et al. 2008), and Myc (Chen et al. 2008;
Sabò et al. 2014) bind to the Skiv2l2 promoter, and microarray studies have demonstrated that Skiv2l2 mRNA increases
with cAMP/PKA activation (Guo et al. 2012). Additionally,
the SKIV2L2 protein has been previously found to be a target
of the MAPK–ERK signaling cascade in mice (Sundaram
2013), and the transcription factor Smad4 has been shown
to regulate Skiv2l2 transcription (Fei et al. 2009). Our research has also demonstrated that chemically differentiating
cancer cell lines down-regulate Skiv2l2 and that decreased
SKIV2L2 levels enhance cell differentiation. Similar to how
autophagy pathways are up-regulated in stem cells due to increased translation (Phadwal et al. 2012), stem cells may also
up-regulate RNA surveillance pathways in response to the
high levels of transcription and protein synthesis that stem
cells require to efficiently divide and maintain pluripotency
(Boisvert et al. 2007). One such gene whose transcription increases in proliferating cells, Rn45s (45S ribosomal RNA precursor), undergoes processing dependent on SKIV2L2www.rnajournal.org
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mediated RNA surveillance (Schilders et al. 2007). In this paper, we have identified replication-dependent histone
mRNAs as another potential SKIV2L2 target whose mRNA
levels increase in proliferating cells. With the switch from
proliferation to post-mitotic differentiation, high levels of
SKIV2L2 and RNA surveillance may no longer be necessary,
resulting in the reduced levels of SKIV2L2 observed in chemically differentiated cells.
Since loss of SKIV2L2 enhances both the differentiation of
N2A cells into cholinergic neurons and P19 cells into cardiac
myocytes, we conclude that SKIV2L2 functions in mouse cells
to maintain pluripotency as opposed to preventing differentiation into a certain cell type. Additionally, the delay in G2/
M phase progression in Skiv2l2 knockdown cells differs
from the canonical G1 arrest seen in chemically or developmentally differentiated cells, suggesting that the differentiation following loss of SKIV2L2 occurs indirectly as opposed
to through direct induction of differentiation pathways.
While the results of mitotic arrest and increased differentiation appear to conflict, there are possible explanations for
the phenotype seen with SKIV2L2 depletion. The differentiation observed in N2A and P19 cells following Skiv2l2 knockdown may result from mitotic stress that generates polyploid
cells unable to undergo apoptosis. Failed cytokinesis following mitotic slippage generates one 4N G1 cell that can undergo apoptosis, enter S phase with significant genomic damage,
or arrest in G1 to either senesce or differentiate (Rieder and
Maiato 2004). This phenomenon of mitotic slippage could
potentially account for the phenotype observed following
SKIV2L2 depletion, as mitotic stress can induce differentiation either naturally or following p53 inhibition (Smith
et al. 1998; Freije et al. 2014). The p53 signaling pathway
has been shown to be inactivated in P19 cell lines (Chang
et al. 2010), lending support to the idea that differentiation
could result from a failure to trigger apoptosis following mitotic slippage in cells depleted of SKIV2L2. We have also demonstrated that SKIV2L2 depletion results in decreased cellular
proliferation, specifically attributed to perturbed progression
through G2/M phase and seen as an increase in G2/M phase
cells, elevated levels of the mitotic marker H3 phospho-S10,
and the observance of binuclear cells. In light of this,
SKIV2L2 may promote efficient progression through the
cell cycle to allow for self-renewal in stem cells. This hypothesis would explain studies in zebrafish, where Skiv2l2 mutants
fail to regenerate melanocytes or tails, presumably due to a
decrease in the stem cell population (Yang et al. 2007).
This research has illuminated SKIV2L2 target RNAs that
could be responsible for perturbed mitotic progression. In
particular, SKIV2L2 depletion in N2A and P19 cells results
in the accumulation of the replication-dependent histone
mRNAs. Histone mRNA levels depend on cell-cycle regulation, with high levels of histone mRNAs necessary in proliferating cells. During S phase, histone mRNA transcription
increases three- to fivefold (Marzluff et al. 2008), but at the
end of S phase, histone mRNA half-life decreases substan920
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tially. Unlike other coding mRNAs, histone mRNAs lack
poly(A) tails, with the processing and stability of the
mRNA depending on the binding of SLBP (stem–loop-binding protein) (Lanzotti et al. 2002; Zhao et al. 2004; Zhang
et al. 2012). The down-regulation of both SLBP and histone
mRNAs at the end of S phase is necessary for cell-cycle progression because the expression of histone proteins outside of
S phase negatively impacts chromosome segregation during
mitosis and may titrate histone modifiers away from chromatin (Meeks-Wagner and Hartwell 1986; Marzluff et al. 2008;
Singh et al. 2010). This research implicates SKIV2L2 in the
turnover of replication-dependent histone mRNAs. In yeast,
loss of Mtr4p results in M phase arrest due to impaired microtubule spindle assembly (Smith et al. 2011), but it is unclear if this is due to a histone imbalance. Additionally, loss
of Trf4p and the exosome component Rrp6p lead to histone
accumulation in yeast (Reis and Campbell 2006; Canavan
and Bond 2007). Similarly, knockdown of Rrp6 in
Drosophila results in the accumulation of histone mRNAs
and inhibits progression into M phase (Graham et al.
2009). However, previous research failed to establish a definitive link between histone turnover and nuclear RNA surveillance components in mammals. The results presented in this
paper demonstrate that SKIV2L2 not only binds histone
mRNAs, but also that SKIV2L2 depletion causes histone
mRNAs to accumulate due to impaired histone mRNA turnover. Together, this offers highly suggestive evidence that at
least one component of nuclear RNA surveillance, the helicase SKIV2L2, mediates the turnover of replication-dependent histone mRNAs. In humans, the discovery that
h3′ exo, an exonuclease responsible for histone mRNA turnover, is not sufficient to displace SLBP and degrade the stem–
loop of histone mRNA (Dominski et al. 2003) lends promise
to the idea that the RNA helicase SKIV2L2 may be necessary
to unwind histone mRNAs prior to degradation. The connection between SKIV2L2 and histone accumulation implies
that SKIV2L2 directs histone mRNAs to the exosome for degradation. In addition, human PM/Scl-100 (Rrp6) has been
shown to be necessary for the degradation of cytoplasmic histone mRNAs (Slevin et al. 2014). The cellular localization of
PM/Scl-100 is primarily nuclear, as it associates with the nuclear exosome (Allmang et al. 1999; Brouwer et al. 2000).
However, certain studies have detected a very small proportion of PM/Scl-100 in the cytoplasm (Lejeune et al. 2003), although this finding is not definitive. Localization studies
detect SKIV2L2 exclusively in the nucleus, with a higher concentration in the nucleolus (Schilders et al. 2007; Lubas et al.
2011, 2015; Osman et al. 2011). To our knowledge, SKIV2L2
has not been detected in the cytoplasm. Since the nuclear
RNA surveillance components PM/Scl-100 and SKIV2L2
have been implicated in the replication-dependent histone
turnover, it is possible that these proteins play a role in cytoplasmic RNA surveillance or a more complicated relationship
exists between histone mRNA turnover and nuclear RNA
surveillance.
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In addition to regulating histone mRNA levels, our data
have implicated SKIV2L2-mediated RNA surveillance in
snoRNA and miRNA biogenesis, lncRNA turnover, and
degradation of transcripts originating from intergenic regions, such as retrotransposed mRNAs, pseudogenes, and
PROMPTs. These targets could also influence proliferation
and pluripotency through various mechanisms. Verifying
and exploring these RNA surveillance targets will drive forward a better understanding of how RNA surveillance can influence RNA transcription and RNA biogenesis pathways on
a more global scale and lead to greater insight on the regulation of mammalian gene expression.
Our studies on SKIV2L2 in mammalian cells establish a
connection between RNA surveillance and cell-cycle progression. While there is a correlation between histone mRNA accumulation and mitotic arrest in Skiv2l2 knockdown cells, the
definitive cause of this phenotype remains elusive. Since
SKIV2L2 functions in nucleolar RNA surveillance, and the
regulation of cell growth and division largely depends on the
nucleolus (Tsai 2014), we hypothesize that the turnover of histone mRNAs or the processing and turnover of nucleolar
RNAs are necessary for mitotic progression. Alternatively,
because SKIV2L2 facilitates the processing of mammalian
pre-rRNAs, SKIV2L2 may enhance the efficiency of rRNA
processing and ribosome assembly, which are necessary to
maintain cell proliferation in actively dividing cells (Boisvert
et al. 2007). Indeed, our data also hint at a central role for
SKIV2L2 in regulating ribosome biogenesis, as cells depleted
of SKIV2L2 accumulate ribosomal protein mRNAs and
show perturbed ribosomal RNA processing (Berndt et al.
2012). Similar to the results seen in this study for SKIV2L2,
the methyltransferase fibrillarin has also drawn a connection
between stem cell maintenance and ribosome biogenesis
(Watanabe-Susaki et al. 2014). Like SKIV2L2, fibrillarin is
necessary for rRNA maturation and highly expressed in embryonic stem cells, with knockdown of fibrillarin inducing differentiation and inhibiting cell growth (Watanabe-Susaki
et al. 2014). In support of the hypothesis SKIV2L2 may induce
differentiation due to impaired ribosome biogenesis, the
down-regulation of rRNAs has been shown to trigger differentiation in human HL-60 and THP-1 cell lines (Hayashi et al.
2014), and ribosomal protein mRNA expression changes during differentiation in human NTERA2 cells (Bevort and
Leffers 2000). While the exact function of SKIV2L2 in the
cell cycle is unclear, an imbalance of at least two SKIV2L2 substrates, histone mRNAs and ribosomal protein mRNAs, could
be responsible for the defects in mitotic progression observed
following Skiv2l2 knockdown. Deeper investigation into the
role of SKIV2L2 and nuclear RNA surveillance in cell-cycle
regulation may prove important in understanding diseases
marked by changes in SKIV2L2, such as cancer.
While noncoding RNAs represent the vast majority of discovered nuclear RNA surveillance targets, it was of great
interest that replication-dependent histone mRNAs accumulate following loss of SKIV2L2-mediated RNA surveillance.

Since histone mRNAs lack a poly(A) tail like many noncoding RNAs (Marzluff et al. 2008), it reasons that the nuclear
turnover of histone mRNAs may be similar to that seen for
noncoding RNAs. Replication-dependent histones are transcribed at high levels during S phase but are rapidly turned
over upon entry into G2 phase (Marzluff et al. 2008).
While the turnover of histones following uridylation in the
cytoplasm has been extensively studied (Kaygun and
Marzluff 2005a,b; Mullen and Marzulff 2008), our research
suggests that SKIV2L2 also mediates the turnover of histone
mRNAs, as SKIV2L2 directly binds histone mRNAs in vivo
and SKIV2L2 depletion increases the half-life of histone H4
mRNA. This histone mRNA turnover could potentially occur
in the nucleus, where SKIV2l2 is localized, or in the cytoplasm following breakdown of the nuclear envelope. Since
SKIV2l2 is necessary for replication-dependent histone
mRNA turnover, it is hypothesized that with SKIV2L2 depletion, histone mRNAs fail to be properly turned over at the
end of S phase, leading to a histone imbalance, which has previously been shown to disrupt mitosis (Meeks-Wagner and
Hartwell 1986; Singh et al. 2010; Günesdogan et al. 2014).
MATERIALS AND METHODS
Cell culture
Neuro2A (N2A, ATCC #CCL-131) cells were grown at 37°C, 5%
CO2, and 95% humidity in DMEM (Sigma-Aldrich #D6429),
10% fetal bovine serum (FBS, Sigma-Aldrich #12306C). Cells
were plated on Greiner Bio-One Advanced TC 35- or 60-mm plates.
Cells were split at 1:5 or 1:10 every 48 h. Differentiation was initiated
by plating the cells in DMEM, 2% FBS, 20 µM all-trans retinoic acid
(ATRA, Sigma-Aldrich #R2625). Cells were harvested after 48 h by
simple pipetting.
P19 cells (ATCC #CRL-1825) were cultured in α-MEM (SigmaAldrich # M8042), 10% FBS (Sigma-Aldrich #12306C) at 37°C,
5% CO2, and 95% humidity. P19 cells were passaged every 48 h
at 1:5 or 1:10. Cells were differentiated using α-MEM growth medium, 10% FBS, 0.1% dimethyl sulfoxide (Sigma-Aldrich #D2438).
Cells were harvested after 48 h by simple pipetting.

RNAi
Before RNAi knockdown, 3 × 105 N2A or P19 cells were plated on
35-mm plates. When cells were at ∼60% confluency, cells were transfected with the appropriate siRNA. Skiv2l2 knockdowns were performed by transfecting cells with either 67 nM Skiv2l2 Silencer
siRNA ID #177475 or #177476 (Thermo Fisher #AM16704,
#AM16708) or 67 nM Negative Control Silencer siRNA by
Ambion (Thermo Fisher #AM4635). Delivery of siRNAs was accomplished with 1 mL of Opti-MEM (Thermo Fisher #31985) and 0.1%
Lipofectamine RNAiMax by Invitrogen (Thermo Fisher #13778) for
N2A cells or 0.1% Lipofectamine 3000 by Invitrogen (Thermo Fisher
#L300008) for P19 cells according to the manufacturer’s protocol.
Cells treated with the siRNAs were grown for 48 h at 37°C, 5%
CO2, and 95% humidity. The cells were then harvested following
RNAi using simple pipetting.
www.rnajournal.org
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Neuronal processes quantification
Following RNAi, N2A cells were counted following treatment with
the Neural Outgrowth Staining kit (Thermo Fisher #A15001) according to the manufacturer’s protocol. Cells were viewed on the
Leica DMI6000 B inverted microscope with excitation at 495 nM
and 555 nM for visualization of the cell viability stain (green) and
the cell membrane stain (orange). Random fields were selected,
and 900 cells were scored for Skiv2l2 and negative control siRNAtreated cells. Cells staining both orange and green (yellow overlay)
with processes extending longer than twice the diameter of the cell
body were counted as differentiated. The number of differentiated
cells was then divided by the total number of cells counted to obtain
the percentage of dead and differentiated cells. Samples were compared using a binomial comparison of proportions and χ2 test.

Protein extraction
Harvested N2A and P19 cells were lysed on ice for 15 min with protein lysis buffer containing 1% Triton-X, 150 mM sodium chloride,
50 mM Tris-HCl pH 8, and cOmplete EDTA-free proteinase inhibitor tablet (04693132001 Roche). Cells were then spun down at
16,000g at 4°C for 15 min, and the supernatant containing the protein was collected. Bradford assays were performed to quantify the
total protein using Bradford Reagent (Sigma-Aldrich #B6916).
Histone proteins were extracted by incubating the nuclear pellet
with 0.2 N HCl overnight at 4°C.

RNA isolation
Cells were lysed in 1 mL TRI Reagent (Sigma-Aldrich #T9424), and
RNA was isolated according to the manufacturer’s protocol. RNA
was DNase treated according to the TURBO DNA-free kit protocol
(Ambion #AM1907) and quantified using the NanoDrop 2000
(Thermo Scientific). RNA isolated from P19 cells for sequencing
was tested for RNA integrity using the RNA 6000 Nano Kit
(Agilent #5067-1511) on the Agilent 2100 Bioanalyzer according
to the manufacturer’s protocol.

Western blotting
Protein extracts in Laemmli buffer were run at 100V on a 10% acrylamide (37.5:1) SDS-PAGE gel. Acid-extracted nuclear fractions
and cytoplasmic fractions were run on separate gels on the same
day. Proteins were then transferred onto BioTrace nitrocellulose
membrane, 0.2 µm pore size (Pall Corporation #66485) at 4°C
and 15 V for 12 h. The membrane was incubated in blotting milk
containing polyclonal antibodies raised in rabbit against mouse
SKIV2L2 (1:1000 dilution, Abcam ab187884), β-actin (1:50 dilution, Thermo Fisher #PA5-16914), or H3 phospho-S10 (1:500 dilution, Abcam ab5176) for 16 h at 4°C, followed by goat anti-rabbit
antibody conjugated to horseradish peroxidase (1:5,000 dilution,
Abcam ab6721) Protein was detected using luminol, ρ-coumaric
acid, and hydrogen peroxide and capturing chemiluminescence
with the UVP Biospectrum System. SKIV2L2 and H3 phosphoS10 protein levels were quantified by normalizing to ACTB using
the ImageJ software provided by the NIH. A Student’s t-test measured significance between control and Skiv2l2 siRNA samples,
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while a one-way ANOVA with Tukey’s HSD test was used with comparison to chemically induced differentiation.

Quantitative RT-PCR
DNase-treated RNA isolated from N2A and P19 cells was reversed
transcribed using oligo-dT or gene-specific primers (Supplemental
Table S6) according to M-MLV reverse transcriptase protocol
(Promega #M1705). PCR cleanup (IBI Scientific, VWR #95039)
was then carried out according to the manufacturer’s protocol on
the reverse transcription reactions, and the reactions were diluted
with DEPC-treated water by a factor of 10. Targets (primers listed
in Supplemental Table S6) were amplified from the reverse transcription reactions using iQ SYBR Green Supermix (BioRad
#1708880). Amplification was detected using the CFX Connect
Real-Time PCR detection system. Cycles 1–35 were analyzed using
regression threshold analysis for samples with no amplification in
control reactions without reverse transcriptase. Target “expression”
(steady-state mRNA level) was calculated using CFX Manager
Software, where expression equals 2−(Cqtarget−CqActB) with targets
normalized to β-actin and control treatment. Statistics were calculated using the Student’s t-test for comparison between control
and Skiv2l2 knockdown. For comparison with ATRA treatment as
well, a one-way ANOVA followed by the Tukey’s HSD test was used.

MTT assay
Immediately following transfection of N2A or P19 cells with negative control siRNA or Skiv2l2 siRNA, cells were harvested and transferred to a 96-well plate. 100 µL of cells were plated in each well, with
10 µL of 5 mg/mL Thiazolyl blue tetrazolium bromide (MTT,
Sigma-Aldrich #M5655) according to the manufacturer’s protocol
at various time points during 37°C incubation. Absorbance of formazan was measured according to the manufacturer’s protocol after
3 h of incubation with MTT. Formazan absorbance was calculated
by subtracting the absorbance at 630 nm from the absorbance at
570 nm for 10 wells per time point. Formazan absorbance was
then used to calculate cell proliferation by dividing any given formazan absorbance by the initial formazan absorbance at the time of
transfection. Overall proliferation at 36 h was calculated for both
N2a and P19 cells, and results were compared using the Student’s
t-test. For comparison between control siRNA, ATRA treatment,
and Skiv2l2 siRNA over time, a one-way ANOVA was used in conjunction with the Tukey’s HSD test at each time point.

Fluorescent activated cell sorting
Following RNAi, knockdown cells were harvested and washed in
PBS supplemented with 2% FBS and resuspended in 1 mL of PBS.
For viability staining, cells were then incubated with 1 U RNaseA
for 1 h at 37°C. 100 µL of 1 mg/mL propidium iodide (Thermo
Fisher #P3566) was added to the cells 20 min before cell sorting
on the BD Accuri C6 cell sorter. Cells were excited with the 488
nm blue laser, and the filter was set to FL-2 to detect propidium iodide fluorescence. 50,000 cells were sorted for each sample, debris
was gated out, and the percentage of stained cells was calculated using the CFlow Plus software. The percentage of stained cells across
the three treatments were compared with a one-way ANOVA in
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conjunction with the Tukey’s HSD test. In addition, cells with increased side-scatter were counted using the CFlow Plus software
and compared across the three treatments with a one-way
ANOVA and Tukey’s HSD test as well.
For cell-cycle analysis, cells were fixed in ice cold ethanol for 30
min, washed twice in PBS, and resuspended in 1 mL PBS. The fixed
cells were then incubated with 1 U RNaseA for 1 h at 37°C. 100 µL of 1
mg/mL propidium iodide (Thermo Fisher #P3566) was added to the
fixed cells 20 min before cell sorting on the BD Accuri C6 cell sorter
as stated above. The percentage of stained cells in G1, S, and G2/M
phase was calculated using the CFlow Plus software based on FL-2
detection (DNA content) and cell count. The percentage of cells in
each cell-cycle phase were compared across the three treatments
with a one-way ANOVA in conjunction with the Tukey’s HSD test.

Indirect immunofluorescence cell imaging
Following RNAi treatment, harvested cells were washed in PBS, 2%
FBS and fixed for 30 min in ice-cold ethanol. After washing in PBS,
0.1% NP-40, pH 7.5, cells were blocked for 60 min at 21°C in PBS,
2% FBS. Cells were then incubated with the primary antibody
against H3 phospho-S10 (1:500 dilution, Abcam ab5176) for 14 h
at 4°C. Cells were again washed before incubation with the secondary antibody anti-rabbit conjugated to AlexaFluor 488 (1:500 dilution, Thermo Fisher #A-11034) for 2 h at 21°C. Cells were washed
and resuspended in 1 mL PBS before viewing 200 µL of cells on
slides. Cells were excited at 488 nm and both brightfield images
and FL-1 filtered images were captured on the Nikon Eclipse E600
microscope. 150 cells per sample were scored based on fluorescence
intensity, with four biological replicates. A Student’s t-test was performed to compare control to Skiv2l2 knockdown samples.

RNA-seq
RNA was harvested from P19 cells as described above on three biological replicates of control siRNA and Skiv2l2 siRNA treated cells.
RNA was tested for quality and treated with DNase and RiboZero
kits to remove DNA and rRNA. Illumina Hi-Seq 2000 paired-end
sequencing was performed at University of Wisconsin-Madison.
FASTQ reads were trimmed and filtered to improve mapping quality before mapping to mm10 genomic build using TopHat, allowing
for no more than two nucleotide mismatches per read and resulting
in 95% mapping efficiency. Galaxy web-based tools were used to
perform cufflinks, and cuffdiff was run to determine differential
transcripts. Transcripts with a q-value less than 0.05 were considered
to be differentially expressed in the Skiv2l2 knockdown cells, and elevated or down-regulated genes showing a fold change >1.5-fold
were probed in detail. Files were converted into BigWig format to
view genome coverage on the IGV Genome Browser. GO-enrichment analysis was run on the GO-ontology consortium website.
Classes of mRNAs were identified using the geneimprint: imprinted
gene database and NCBI. Statistics were performed in R Studio using the phyper function.

Protein–RNA immunoprecipitation
After 48 h of cell growth, untreated P19 and N2A cells were irradiated at 254 nm (150 mJ/cm2) to crosslink proteins and RNA using

the UVP Crosslinker CL-1000 model. Protein A conjugated
Dynabeads were prepared according to the manufacturer’s protocol
using the Dynabeads Protein A Immunoprecipitation Kit (Thermo
Fisher #10006D). Dynabeads were incubated with 3 µg of rabbit
polyclonal antibody against SKIV2L2 (Abcam #ab70552). Cells
were lysed as described previously. Cellular lysate prepared UV irradiated cells were loaded onto the Dynabeads and incubated according to kit protocol. Immunoprecipation of SKIV2L2 according to kit
protocol was performed, and the protein–RNA complexes were
eluted off the Dynabeads. Eluate was treated with DNase and proteinase K. Samples of whole cell extracts (8 µL) after application
to beads and immunoprecipitate after application to beads, washing,
and elution (1 µL) were taken for Western blotting to verify recovery
of SKIV2L2 protein, while RNA was isolated from eluate using
TRIzol extraction with chloroform as previously described. cDNA
preparation and qPCR were performed on the isolated RNA as mentioned previously. As Skiv2l2 mRNA did not immunoprecipitate
with anti-SKIV2L2, Skiv2l2 mRNA target Cq values were representative of fluctuations in background fluorescence. Experimental Cq
values were normalized to Skiv2l2 mRNA Cq values. The Student’s
t-test was performed to compare mRNA levels for anti-goat-Ig and
anti-SKIV2L2 samples for three trials.

RNA decay assay
Following 24 h of control and Skiv2l2 RNAi as previously described,
N2A cells were treated with Dactinomycin (Sigma #A1410) to a
concentration of 5 µg/mL. Cells were harvested for RNA extraction
at 0, 1, 2, 3, and 4 h. RNA was quantified and 8 µL of identical
amounts of RNA (approximately 8 µg) were run on a 1.4% agarose
gel at 90V. RNA was transferred to a blotting membrane overnight
in 20X SSC before being crosslinked to the membrane. The
Northern blot was probed using primers against H4 and ActB.
Primers were radiolabeled with ATP, [γ-32P]-3000Ci/mmol
10mCi/ml EasyTide Lead (PerkinElmer), using T4-polynucleotide
kinase (NEB #M0201) according to the manufacturer’s protocol.
Radiolabeled probes were incubated with the blot at 42°C for 16 h
and developed using phosphorimaging screens and the Storm
PhosphorImager from GE Healthcare. Peak quantification for H4
mRNA and rRNA was performed on Image J software, and H4
mRNA levels were normalized to 5S rRNA. The decay constant
was calculated using the equation ln(C/C0) = −kdecayt, where t =
time, kdecay = decay constant, C = RNA level at t, and C0 = RNA level
at t = 0. H4 half-life (t1/2) was found by solving for t at ln(0.5). This
half-life was calculated at every hour, 2, 3, and 4 h. These values were
averaged to determine the overall half-life for each trial. The
Student’s t-test was performed on the H4 half-life calculated for
three distinct trials.

SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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